Improving Screening
and Early Diagnosis of Alpha-1
Antitrypsin Deficiency (AATD):

Why Is the Unacceptable, Acceptable?

The multidisciplinary team plays a critical role in the diagnosis and management of alpha-1 antitrypsin deficiency (AATD). Yet, AATD is underrecognized, even though early identification is so critical. This educational tool supports an easy translation of knowledge and encourages informed decision making for screening and testing patients who have a high probability for AATD.

This activity focuses on:

  • improving awareness, detection, and management of AATD

  • evidence-based strategies to screen and test patients for AATD

  • benefits of earlier institution of AAT augmentation therapy to slow the progression of comorbidities in affected individuals


Caroline Jouhourian, MD

Caroline Jouhourian, MD


Beth Israel Deaconess Medical Center

Boston, MA

Cheryl Pirozzi MD, MS

Cheryl Pirozzi MD, MS

Pulmonary and Critical Care Medicine

University of Utah

Salt Lake City, UT